Paper32733
Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure.
Nielsen NV. Acta Ophthalmol (Copenh), 1978. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure. Papers, record 32733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glaucoma | Major topic |
| Intraocular Pressure | Major topic |
| Propanolamines | Major topic |
| Timolol | Major topic |
| Acetazolamide | |
| Adrenergic beta-Antagonists | |
| Adult | |
| Aged | |
| Drug Therapy, Combination | |
| Drug Tolerance | |
| Epinephrine | |
| Female | |
| Headache | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilocarpine |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7387959 | Timolol in operated closed-angle glaucoma. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/7387959 | PubMed |
| 7075965 | The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. | Graefes Arch Clin Exp Ophthalmol | 1982 | https://conductscience.org/library/papers/7075965 | PubMed |
| 7028085 | Study of the additive effect of timolol and epinephrine in lowering intraocular pressure. | Br J Ophthalmol | 1981 | https://conductscience.org/library/papers/7028085 | PubMed |
| 7000172 | Addition of timolol maleate to routine medical therapy: a clinical trial. | Br J Ophthalmol | 1980 | https://conductscience.org/library/papers/7000172 | PubMed |
| 6338905 | Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma. | Br J Ophthalmol | 1983 | https://conductscience.org/library/papers/6338905 | PubMed |
| 373489 | The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1979 | https://conductscience.org/library/papers/373489 | PubMed |
| 369807 | Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma. | Drugs | 1979 | https://conductscience.org/library/papers/369807 | PubMed |
| 317629 | [Timolol and acetazolamide in the treatment of increased intraocular pressure (author's transl)]. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1979 | https://conductscience.org/library/papers/317629 | PubMed |
| 37770 | [The effect of timolol and parasympathicomimetica in the treatment of the elevated intraocular pressure (author's transl)]. | Albrecht Von Graefes Arch Klin Exp Ophthalmol | 1979 | https://conductscience.org/library/papers/37770 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32733
GET https://conductscience.org/api/papers/v1/32733/authors